1. World Health Report. Geneva: World Health Organization. Available from URL: http://www.who.int/whr/2000/en/statistics.htm; 2000.
2. Lopez AD, Shibuya K, Rao C et al. Chronic obstructive pulmonary disease: current burden and future projections. Eur Respir J 2006; 27 (2): 397–412.
3. Глобальная стратегия диагностики, лечения и профилактики хронической обструктивной болезни легких. Пересмотр 2008 г. Перев. с англ. М.: Атмосфера, 2009.
4. Huang SL, Su CH, Chang SC. Tumor necrosis factor-alpha gene polymorphism in chronic bronchitis. Am J Respir Crit Care Med 1997; 156 (5): 1436–9.
5. Smith CA, Harrison DJ. Association between polymorphism in gene for microsomal epoxide hydrolase and susceptibility to emphysema. Lancet 1997; 350 (9078): 630–3.
6. Wu L, Chau J, Young RP et al. Transforming growth factor-beta 1 genotype and susceptibility to chronic obstructive pulmonary disease. Thorax 2004; 59 (2): 126–9.
7. Stoller JK, Aboussouan LS. Alpha1-antitrypsin deficiency. Lancet 2005; 365 (9478): 2225–36.
8. Laurell CB, Eriksson S. The electrophoretic pattern alpha1-globulin pattern of serum in alpha1-antitrypsin deficiency. Scan J Clin Lab Invest 1963; 15: 132–40.
9. Генетика бронхолегочных заболеваний. Под ред. В.П.Пузырева, Л.М.Огородовой. Серия монографий Российского респираторного общества. Гл. ред. А.Г.Чучалин. М.: Атмосфера, 2010.
10. Standards for the Diagnosis and Management of Individuals with Alpha-1 Antitrypsin Deficiency. Am J Respir Crit Care Med 2003; 168: 818–900.